Chronic Spontaneous Urticaria (CSU) Overview

Save information for later
Sign Up

Learn About Chronic Spontaneous Urticaria (CSU)

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Chronic Spontaneous Urticaria (CSU) Local Doctors?
Internal Medicine
Internal Medicine
101 Walnut St, 
Kane, PA 
 (17.0 mi)
Languages Spoken:
English

Gary Anderson is an Internal Medicine provider in Kane, Pennsylvania. Dr. Anderson and is rated as an Experienced provider by MediFind in the treatment of Chronic Spontaneous Urticaria (CSU). His top areas of expertise are Pachydermoperiostosis, Neuromyelitis Optica, Diffuse Panbronchiolitis, and Complex Regional Pain Syndrome.

90 Beaver Dr, Ste 122-d, 
Du Bois, PA 
 (20.6 mi)
Languages Spoken:
English

Richard Johnson is a Dermatologist in Du Bois, Pennsylvania. Dr. Johnson and is rated as an Experienced provider by MediFind in the treatment of Chronic Spontaneous Urticaria (CSU). His top areas of expertise are Rosacea, Seborrheic Keratosis, Sunburn, and Actinic Keratosis.

 
 
 
 
Learn about our expert tiers
Learn More
Family Medicine
Family Medicine
18 W Main St, 
Mt Jewett, PA 
 (21.5 mi)
Languages Spoken:
English

Linda Rettger is a Family Medicine provider in Mt Jewett, Pennsylvania. Dr. Rettger and is rated as an Experienced provider by MediFind in the treatment of Chronic Spontaneous Urticaria (CSU). Her top areas of expertise are Alzheimer's Disease, Anemia, Maturity Onset Diabetes of the Young, and Chronic Obstructive Pulmonary Disease (COPD).

What are the latest Chronic Spontaneous Urticaria (CSU) Clinical Trials?
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients With Chronic Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment (EMBARQ-CSU1)

Summary: The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating second generation H1-antihistamines in comparison to placebo.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients With Chronic Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment (EMBARQ-CSU2)

Summary: The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating second generation H1-antihistamines in comparison to placebo.